SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-09-037403
Filing Date
2009-06-09
Accepted
2009-06-09 15:09:36
Documents
18

Document Format Files

Seq Description Document Type Size
1 425 a09-15223_1425.htm 425 31291
2 GRAPHIC g152231bai001.gif GRAPHIC 113287
3 GRAPHIC g152231bai002.gif GRAPHIC 115005
4 GRAPHIC g152231bai003.gif GRAPHIC 47956
5 GRAPHIC g152231bai004.gif GRAPHIC 77906
6 GRAPHIC g152231bai005.gif GRAPHIC 60676
7 GRAPHIC g152231bai006.gif GRAPHIC 46163
8 GRAPHIC g152231bai007.gif GRAPHIC 36189
9 GRAPHIC g152231bai008.gif GRAPHIC 44888
10 GRAPHIC g152231bai009.gif GRAPHIC 32422
11 GRAPHIC g152231bai010.gif GRAPHIC 35625
12 GRAPHIC g152231bai011.gif GRAPHIC 54701
13 GRAPHIC g152231bai012.gif GRAPHIC 56645
14 GRAPHIC g152231bai013.gif GRAPHIC 31007
15 GRAPHIC g152231bai014.gif GRAPHIC 43744
16 GRAPHIC g152231bai015.gif GRAPHIC 58096
17 GRAPHIC g152231bai016.gif GRAPHIC 45889
18 GRAPHIC g152231bai017.gif GRAPHIC 112061
  Complete submission text file 0001104659-09-037403.txt   1430828
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filed by) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-15006 | Film No.: 09881936
SIC: 2835 In Vitro & In Vivo Diagnostic Substances